Skip to main content
. 2004 Jul 21;101(31):11368–11373. doi: 10.1073/pnas.0402979101

Table 1. Characteristics of tumors and their amplicons.

Characteristic Case 4 Case 7 Case 14 Case 21 Case 22 Case 30 Case 34
Histology* ODA GBM ODA GBM ODA GBM GBM
Material N/F/X X N/F/X F/X F/X F F
Chromosomes 90 45 47 70 47 91 47
Chromosomes 7§ 6 3 3 3 3 6
Amplification
    Xenograft 9 (7-13) 8 (5-12) 17 (12-24) 32 (22-45) 55 (40-70)
    Fresh 10 (7-14) 17 (13-25) 30 (20-45) 60 (55-80) 30 (20-40) 63 (50-80)
Amplicon
    5′ Breakpoint 54,492,001 54,168,756 47,078,805 53,489,375 54,349,769 53,426,589 54,440,318
    3′ Breakpoint 56,100,888 55,697,845 55,057,216 55,121,943 55,056,001 55,562,319 55,641,516
    Length, bp 1,608,892 1,529,091 941,200 1,530,714 706,234 2,099,732 1,201,200
Deletion
    5′ Breakpoint 47,118,693 54,862,131
    3′ Breakpoint 54,155,906 54,963,991
    Length, bp 7,037,214 101,865

ODA, oligodendroglioma; GBM, glioblastoma multiforme; N, normal tissue; F, fresh tumor; X, xenografted tumor.

*

Histological types.

Available biological material.

Modal chromosome number estimated from analysis of R-banded metaphase chromosomes.

§

Number of chromosomes 7 determined by FISH with chromosome 7 painting probes.

Mean level of amplification. Experimental ranges are given in parentheses.

Localization of the breakpoints that generated the amplicons and their internal deletions. Breakpoints are arbitrarily located at the first base found outside of the region of microhomology (see Fig. 3). Positions are indicated according to the human genome sequence published on the University of California, Santa Cruz (UCSC) Genome Bioinformatics web site (release date July 2003).